Literature DB >> 21517238

Survival of thyroid cancer and social determinants in Iran, 2001-2005.

Maryam Khayamzadeh1, Marjan Khayamzadeh, Niki Tadayon, Reza Salmanian, Hanieh Zham, Zahra Razzaghi, Mohammad Esmaeil Akbari.   

Abstract

BACKGROUND: Thyroid cancer is the most common endocrine system malignancy in the world, being the 7th most common cancer in females, 14th in males and 11th in both sexes in the Iranian population. The present study aimed to determine survival of thyroid cancers in Iran based on sex, age group, pathology and geographical location.
METHODS: The patients selected for this study were 602 out of 5,759 cases listed in the cancer registry system between 2001 and 2005. The Kaplan-Meier method was used for survival estimation and Cox's proportional hazard model for calculating hazard ratios according to demographic and risk variables.
RESULTS: The overall 5-year survival rate was 88.0%. There was a significant difference between survivals of the two sexes. The best and worst survival were in the age groups under 40 and over 60 years old, respectively. The best survival was for papillary type, with the anaplastic type demonstrating the worst survival. The best survival was in the southwest (Khuzestan) and the worst in the northwest (Azarbaijan).
CONCLUSION: Size of young population and social determinants may be important effective elements for differences in survival, which should be taken more into consideration in managing chronic disease such as thyroid cancer.

Entities:  

Mesh:

Year:  2011        PMID: 21517238

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  6 in total

1.  Recent Trends and Geographical Distribution of Thyroid Cancer in Iran from 2004 to 2009.

Authors:  Ali Safavi; Rozita Jafari; Samira Chaibakhsh; Rashid Ramezani-Daryasar; Mansour Rezaei; Amir Ali Safavi
Journal:  Iran J Cancer Prev       Date:  2014

2.  Survival of Patients with Thyroid Cancer in Yazd, Iran

Authors:  Hassan Ali Vahedian Ardakani; Mansour Moghimi; Mohammad Shayestehpour; Masoud Doosti; Shamsi Beigi Sharifabadi
Journal:  Asian Pac J Cancer Prev       Date:  2017-08-27

3.  Association of the Asp1312Gly Thyroglobulin Gene Polymorphism with Susceptibility to Differentiated Thyroid Cancer in an Iranian Population

Authors:  Maryam Abidi; Shima Fayaz; Pezhman Fard Esfahani
Journal:  Asian Pac J Cancer Prev       Date:  2017-02-01

Review 4.  A review of incidence and mortality of colorectal, lung, liver, thyroid, and bladder cancers in Iran and compared to other countries.

Authors:  Bagher Farhood; Behzad Raei; Reza Malekzadeh; Maryam Shirvani; Masoud Najafi; Tohid Mortezazadeh
Journal:  Contemp Oncol (Pozn)       Date:  2019-04-05

5.  FNAC accuracy in diagnosis of thyroid neoplasms considering all diagnostic categories of the Bethesda reporting system: A single-institute experience.

Authors:  Fatemeh Hajmanoochehri; Elham Rabiee
Journal:  J Cytol       Date:  2015 Oct-Dec       Impact factor: 1.000

Review 6.  Liquid Biopsy as a Minimally Invasive Source of Thyroid Cancer Genetic and Epigenetic Alterations.

Authors:  Fatemeh Khatami; Bagher Larijani; Shirzad Nasiri; Seyed Mohammad Tavangar
Journal:  Int J Mol Cell Med       Date:  2019-05-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.